Bio-Rad Laboratories BIO Life Science — Cost of goods sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's life science — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's life science — cost of goods sold?
- Bio-Rad Laboratories (BIO) reported life science — cost of goods sold of $100.9M in Q1 2026.
- How has Bio-Rad Laboratories's life science — cost of goods sold changed year-over-year?
- Bio-Rad Laboratories's life science — cost of goods sold increased by 0.7% year-over-year, from $100.2M to $100.9M.
- What is the long-term trend for Bio-Rad Laboratories's life science — cost of goods sold?
- Over 3 years (2022 to 2025), Bio-Rad Laboratories's life science — cost of goods sold has grown at a -4.2% compound annual growth rate (CAGR), from $532.7M to $468M.
- What does life science — cost of goods sold mean?
- The direct costs attributable to the production of goods sold by the Life Science segment, including raw materials, direct labor, and manufacturing overhead. This metric is essential for calculating the segment's gross margin.